Skip to main content

Table 4 Clinical correlations in the R and NR group (T0 and T12)

From: Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis

 DAS28-CRPSDAICDAITJCTJC28SJCSJC28HAQVAS medVAS patVAS painVAS fatigue
R group
 SAA
  a3.05e−061.04e−055.14e−052.6e−044.22e−042.53e−066.0e−050.011.54e−050.0021.7e−040.003
  b0.4740.4510.4180.3820.3680.4800.4140.2740.4450.3210.3930.323
 CRP
  a2.98e−071.52e−061.83e−054.35e−056.82e−052.18e−065.58e−050.0223.05e−064.3e−047.9e−030.009
  b0.5140.4870.4400.4240.4110.4830.4160.2430.4770.3680.4590.282
 CBG_serum
  an.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.s
  b
 CBG_eluate
  a0.0050.014n.s0.0370.016n.sn.sn.s0.048n.sn.sn.s
  b− 0.298− 0.262− 0.224− 0.256− 0.213
 LBP_serum
  a6.34e−063.21e−051.23e−043.59e−043.49e−045.19e−064.33e−050.0041.0e−040.0024.4e−040.025
  b0.4610.4280.3980.3740.3730.4670.4210.3060.4050.3260.3690.244
 LBP_eluate
  a0.0040.0140.0370.0090.003n.sn.s.n.s0.047n.sn.sn.s
  b− 0.303− 0.261− 0.222− 0.280− 0.309− 0.214
NR group
 SAA
  an.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.s0.009
  b0.284
 CRP
  an.sn.sn.sn.sn.sn.sn.sn.s0.048n.sn.sn.s
  b0.208
 CBG_serum
  an.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.s
  b
 CBG_eluate
  an.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.s
  b
 LBP_serum
  a0.0050.048n.sn.sn.s0.036n.sn.s0.04n.sn.sn.s
  b0.2920.2060.220.216
 LBP_eluate
  an.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.sn.s
  b
  1. To determine the statistical correlations among proteins and the clinical measures, the Spearman’s rank correlation coefficient was calculated. Only the significant correlations are indicated; a: P-value; b: correlation coefficient
  2. n.s not significant